Home >
Medicine Info >
Dabigat 150 Capsule
Loading interface...

Dabigat 150 Capsule

Manufactured byNatco Pharma Ltd.
ContainsDabigatran
Description
Dabigat 150 Capsule is an anticoagulant (blood thinner) that is used in the prevention and treatment of blood clots. It works by blocking a substance (thrombin) in your body that is involved in blood clot formation. Dabigat 150 Capsule may cause side effects such as bleeding, indigestion, stomach pain, diarrhoea, nausea, etc. Consult your doctor if these symptoms persist or worsen. Dabigat 150 Capsule should be taken exactly as directed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Continue taking this medicine for the prescribed duration to effectively treat your condition. Dabigat 150 Capsule should be avoided if you are allergic to it. Inform your doctor if you have pre-existing kidney or liver problems before beginning treatment with this medicine. Inform your doctor if you are taking any other medicines to avoid any undesired side effects. This medicine is not recommended for use in children below 18 years of age. If you are pregnant, breastfeeding, or are planning a pregnancy, consult your doctor before taking this medication.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Substitutes

List of substitutes for Dabigat 150 Capsule

Pradaxa 150 Capsule
Boehringer Ingelheim India Pvt. Ltd.
Afogatran 150 Capsule
Torrent Pharmaceuticals Ltd.
Dabiclot 150 Capsule
Alkem Laboratories Ltd.
Dabigza 150 Capsule
Glenmark Pharmaceuticals Ltd.
Dablexa 150 Capsule
Abbott Healthcare Pvt. Ltd.

Side effects

Major & minor side effects for Dabigat 150 Capsule

  • Unusual bleeding
  • Decreased red blood cell count
  • Stomach pain
  • Indigestion
  • Diarrhoea
  • Nausea
  • Coughing up blood
  • Reduced Platelet Count
  • Stomach ulcer
  • Itching of skin
  • Vomiting

Uses of Dabigat 150 Capsule

What is it prescribed for?

  • Prevention and treatment of blood clots
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required by Dabigat 150 Capsule to show its effect is not clinically known.
  • How long do the effects of this medicine last?
    Dabigat 150 Capsule remains in your body for an approximate duration of three to four days after intake.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies have been reported with Dabigat 150 Capsule.
  • Can this medicine be taken during pregnancy?
    Dabigat 150 Capsule may harm your developing foetus and is not recommended during pregnancy unless necessary. Hence, consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    It is not known whether Dabigat 150 Capsule passes into breastmilk. Hence this medicine is not recommended for use during breastfeeding unless necessary. Consult your doctor if you are breastfeeding.

Allergy

Avoid taking Dabigat 150 Capsule if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.

Severe kidney impairment

Dabigat 150 Capsule is eliminated by the kidneys. Hence it is not recommended for use if you have severe kidney impairment (loss of kidney function) due to the increased risk of side effects resulting from the accumulation of this medicine in your body.

Active bleeding

Dabigat 150 Capsule is not recommended for use if you have active bleeding problems or any other conditions that may increase your risk of bleeding such as stomach ulcers (painful sores on the inner lining of your stomach), injury/bleeding in your brain, recent surgery of your brain/eyes, etc. This medicine may further increase the risk of bleeding and worsen your condition.

Severe liver disease

Dabigat 150 Capsule is not recommended for use if you have severe liver problems due to the increased risk of a further worsening of your condition.
Warnings for special population

Pregnancy

Dabigat 150 Capsule may harm your developing foetus and is not recommended during pregnancy unless necessary. Hence, consult your doctor if you are pregnant.

Breast-feeding

It is not known whether Dabigat 150 Capsule passes into breastmilk. Hence this medicine is not recommended for use during breastfeeding unless necessary. Consult your doctor if you are breastfeeding.
General warnings

Surgery

Dabigat 150 Capsule may increase your risk of bleeding and should be discontinued at least 24 hours before surgical procedure. If you are at a higher risk of bleeding or in case of major surgery, your doctor may consider the discontinuation of Dabigat 150 Capsule two to four days before surgery. Hence, inform your doctor about the use of this medicine before undergoing any surgery.

Other Medicines

Dabigat 150 Capsule may interact with other medicines and cause undesired effects. Inform your doctor about your current medicines including any herbs or supplements before taking Dabigat 150 Capsule.

Antiphospholipid syndrome

Dabigat 150 Capsule is not recommended for use if you have a history of blood clots formation associated with antiphospholipid syndrome (a condition in which your immune system malfunctions and increases your risk of blood clots). Hence inform your doctor if you have such a condition before beginning treatment with this medicine.

Use in children

Dabigat 150 Capsule is not recommended for use in children below 18 years of age due to a lack of safety and efficacy data.

Women of childbearing potential

Women of childbearing potential should avoid pregnancy during treatment with Dabigat 150 Capsule due to the increased risk of side effects in the foetus.

Missed Dose

Try not to skip a dose of Dabigat 150 Capsule. Take the missed dose as soon as you remember. If it is time for your next dose, skip the missed one. Do not double the dose to compensate for a missed one.

Overdose

Do not take more than the prescribed dose. Contact your doctor if you suspect an overdose with Dabigat 150 Capsule.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Verapamil

Phenytoin

Carbamazepine

Tacrolimus

Amiodarone

Quinidine

Warfarin

Ritonavir

Ticagrelor

Ibuprofen

Ketoconazole

Heparin

Cyclosporine

Aspirin

Diclofenac

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take Dabigat 150 Capsule with or without food. Do not take more or less than the prescribed dose. Avoid the discontinuation of this medicine without consulting your doctor as it may worsen your condition. Dabigat 150 Capsule may increase your risk of bleeding. Inform your doctor if you experience any signs and symptoms of bleeding such as dizziness, lightheadedness, red/black tarry stools, coughing up or vomiting blood, severe headache, and weakness. Dabigat 150 Capsule may decrease your haemoglobin levels, and platelet and red blood cell count. Your doctor may suggest tests to regularly monitor your haemoglobin level and blood cell count during treatment with this medicine.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Dabigat 150 Capsule belongs to a group of medicine called anticoagulants (blood thinners). It works by blocking a substance (thrombin) in your body that is involved in the formation of blood clots.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Thrombin inhibitors, Anticoagulants

Schedule

Schedule H

Medicines.org.uk. 2021. Pradaxa 150 mg hard capsules - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: [Accessed 10 November 2021].

https://www.medicines.org.uk/emc/product/4703/smpc

Medicines.org.uk. 2021. [online] Available at: [Accessed 10 November 2021].

https://www.medicines.org.uk/emc/files/pil.4703.pdf

Accessdata.fda.gov. 2021. [online] Available at: [Accessed 10 November 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022512s028lbl.pdf

Drugs, H., 2021. Dabigatran: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: [Accessed 10 November 2021].

https://medlineplus.gov/druginfo/meds/a610024.html

Ebs.tga.gov.au. 2021. TGA eBS - Product and Consumer Medicine Information Licence. [online] Available at: [Accessed 10 November 2021].

https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2009-PI-01177-3&d=20211110172310101

Rad-ar.or.jp. 2021. Search results detail| Kusurino-Shiori(Drug information Sheet). [online] Available at: [Accessed 10 November 2021].

https://www.rad-ar.or.jp/siori/english/kekka.cgi?n=2023
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 14 Feb 2023

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.